CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 4 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,728,876 | -13.9% | 318,980 | -1.0% | 0.08% | -10.1% |
| Q2 2023 | $4,332,438 | -18.0% | 322,354 | +1.1% | 0.09% | -17.6% |
| Q1 2023 | $5,284,842 | -10.6% | 318,748 | +0.3% | 0.11% | -11.5% |
| Q4 2022 | $5,911,880 | +83.4% | 317,843 | +26.5% | 0.12% | +79.4% |
| Q3 2022 | $3,223,000 | +85.0% | 251,193 | +1.1% | 0.07% | +106.1% |
| Q2 2022 | $1,742,000 | +56.0% | 248,522 | +84.4% | 0.03% | +94.1% |
| Q1 2022 | $1,117,000 | +274.8% | 134,779 | +206.6% | 0.02% | +325.0% |
| Q4 2021 | $298,000 | – | 43,959 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |